Fabry's disease overview: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Fabry's disease}} {{CMG}} ==Overview== '''Fabry disease''' is an X-linked recessive inherited lysosomal storage disease, characterized by abnormal accumulation of ..." |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
'''Fabry disease''' is an [[X-linked recessive]] inherited [[lysosomal storage disease]], characterized by abnormal accumulation of ceramide trihexose in cardiovascular and renal systems. | '''Fabry's disease''' is an [[X-linked recessive]] inherited [[lysosomal storage disease]], characterized by abnormal accumulation of ceramide trihexose in cardiovascular and renal systems. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 18:41, 22 August 2012
|
Fabry's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fabry's disease overview On the Web |
|
American Roentgen Ray Society Images of Fabry's disease overview |
|
Risk calculators and risk factors for Fabry's disease overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Fabry's disease is an X-linked recessive inherited lysosomal storage disease, characterized by abnormal accumulation of ceramide trihexose in cardiovascular and renal systems.